Search Results - "IWATA, Nakao"

Refine Results
  1. 1

    Memantine monotherapy for Alzheimer's disease: a systematic review and meta-analysis by Matsunaga, Shinji, Kishi, Taro, Iwata, Nakao

    Published in PloS one (10-04-2015)
    “…We performed an updated meta-analysis of randomized placebo-controlled trials testing memantine monotherapy for patients with Alzheimer's disease (AD). The…”
    Get full text
    Journal Article
  2. 2

    Mood stabilizers and/or antipsychotics for bipolar disorder in the maintenance phase: a systematic review and network meta-analysis of randomized controlled trials by Kishi, Taro, Ikuta, Toshikazu, Matsuda, Yuki, Sakuma, Kenji, Okuya, Makoto, Mishima, Kazuo, Iwata, Nakao

    Published in Molecular psychiatry (01-08-2021)
    “…We searched Embase, PubMed, and CENTRAL from inception until 22 May 2020 to investigate which antipsychotics and/or mood stabilizers are better for patients…”
    Get full text
    Journal Article
  3. 3

    Brain-Derived Neurotrophic Factor and Major Depressive Disorder: Evidence from Meta-Analyses by Kishi, Taro, Yoshimura, Reiji, Ikuta, Toshikazu, Iwata, Nakao

    Published in Frontiers in psychiatry (17-01-2018)
    “…Accumulating evidence suggests that brain-derived neurotrophic factor (BDNF) is associated with the pathophysiology of major depressive disorder (MDD). In this…”
    Get full text
    Journal Article
  4. 4

    Genetic analysis of quantitative traits in the Japanese population links cell types to complex human diseases by Kanai, Masahiro, Akiyama, Masato, Takahashi, Atsushi, Matoba, Nana, Momozawa, Yukihide, Ikeda, Masashi, Iwata, Nakao, Ikegawa, Shiro, Hirata, Makoto, Matsuda, Koichi, Kubo, Michiaki, Okada, Yukinori, Kamatani, Yoichiro

    Published in Nature genetics (01-03-2018)
    “…Clinical measurements can be viewed as useful intermediate phenotypes to promote understanding of complex human diseases. To acquire comprehensive insights…”
    Get full text
    Journal Article
  5. 5

    Polygenic risk score as clinical utility in psychiatry: a clinical viewpoint by Ikeda, Masashi, Saito, Takeo, Kanazawa, Tetsufumi, Iwata, Nakao

    Published in Journal of human genetics (01-01-2021)
    “…Genome-wide association studies (GWASs) have detected many susceptible variants for common diseases, including psychiatric disorders. However, because of the…”
    Get full text
    Journal Article
  6. 6

    Differences in the incidence of lurasidone adverse events between depressive disorders and schizophrenia in double-blind, randomized, placebo-controlled trials: a meta-analysis by Kishi, Taro, Nakamura, Hiroshi, Iwata, Nakao

    Published in Psychopharmacology (01-12-2021)
    “…Rationale We conducted a meta-analysis of double-blind, randomized placebo-controlled trials of lurasidone (LUR) to examine the difference in the risk ratios…”
    Get full text
    Journal Article
  7. 7

    Memantine for Alzheimer's Disease: An Updated Systematic Review and Meta-analysis by Kishi, Taro, Matsunaga, Shinji, Oya, Kazuto, Nomura, Ikuo, Ikuta, Toshikazu, Iwata, Nakao

    Published in Journal of Alzheimer's disease (01-01-2017)
    “…The clinical benefit of memantine for Alzheimer's disease (AD) remains inconclusive. We performed an updated systematic review and meta-analysis of the…”
    Get more information
    Journal Article
  8. 8

    Pharmacological treatment for bipolar mania: a systematic review and network meta-analysis of double-blind randomized controlled trials by Kishi, Taro, Ikuta, Toshikazu, Matsuda, Yuki, Sakuma, Kenji, Okuya, Makoto, Nomura, Ikuo, Hatano, Masakazu, Iwata, Nakao

    Published in Molecular psychiatry (01-02-2022)
    “…A systematic review and random-effects model network meta-analysis was conducted to compare the efficacy, acceptability, tolerability, and safety of…”
    Get full text
    Journal Article
  9. 9

    Suvorexant for Primary Insomnia: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials by Kishi, Taro, Matsunaga, Shinji, Iwata, Nakao

    Published in PloS one (28-08-2015)
    “…We performed a systematic review and meta-analysis of double-blind, randomized, placebo-controlled trials evaluating suvorexant for primary insomnia. Relevant…”
    Get full text
    Journal Article
  10. 10

    Lemborexant vs suvorexant for insomnia: A systematic review and network meta-analysis by Kishi, Taro, Nomura, Ikuo, Matsuda, Yuki, Sakuma, Kenji, Okuya, Makoto, Ikuta, Toshikazu, Iwata, Nakao

    Published in Journal of psychiatric research (01-09-2020)
    “…We conducted a random-effects model network meta-analysis to examine differences between lemborexant and suvorexant in efficacy and safety outcomes for…”
    Get full text
    Journal Article
  11. 11
  12. 12

    N-acetylcysteine as an adjunctive treatment for bipolar depression and major depressive disorder: a systematic review and meta-analysis of double-blind, randomized placebo-controlled trials by Kishi, Taro, Miyake, Nobumi, Okuya, Makoto, Sakuma, Kenji, Iwata, Nakao

    Published in Psychopharmacology (01-11-2020)
    “…Rationale It remains unclear whether using N-acetylcysteine as an adjunctive treatment has any benefit for bipolar depression and major depressive disorder…”
    Get full text
    Journal Article
  13. 13

    Memantine add-on to antipsychotic treatment for residual negative and cognitive symptoms of schizophrenia: a meta-analysis by Kishi, Taro, Matsuda, Yuki, Iwata, Nakao

    Published in Psychopharmacology (01-07-2017)
    “…Rationale We examined whether memantine add-on to antipsychotic treatment is beneficial in schizophrenia treatment. Objective This systematic review and…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Recurrence rates in stable bipolar disorder patients after drug discontinuation v. drug maintenance: a systematic review and meta-analysis by Kishi, Taro, Matsuda, Yuki, Sakuma, Kenji, Okuya, Makoto, Mishima, Kazuo, Iwata, Nakao

    Published in Psychological medicine (01-11-2021)
    “…This random-effects model meta-analysis of double-blind, randomized placebo-controlled trials compared recurrence rates in bipolar disorder (BD) patients…”
    Get more information
    Journal Article
  16. 16

    Association between circadian activity rhythms and mood episode relapse in bipolar disorder: a 12-month prospective cohort study by Esaki, Yuichi, Obayashi, Kenji, Saeki, Keigo, Fujita, Kiyoshi, Iwata, Nakao, Kitajima, Tsuyoshi

    Published in Translational psychiatry (13-10-2021)
    “…A significant proportion of patients with bipolar disorder experience mood episode relapses. We examined whether circadian activity rhythms were associated…”
    Get full text
    Journal Article
  17. 17

    Aripiprazole vs. brexpiprazole for acute schizophrenia: a systematic review and network meta-analysis by Kishi, Taro, Ikuta, Toshikazu, Matsuda, Yuki, Sakuma, Kenji, Iwata, Nakao

    Published in Psychopharmacology (01-05-2020)
    “…Rationale What is the difference between aripiprazole and brexpiprazole? Objectives This systematic review, network meta-analysis of randomized trials…”
    Get full text
    Journal Article
  18. 18

    Genome‐wide association studies of bipolar disorder: A systematic review of recent findings and their clinical implications by Ikeda, Masashi, Saito, Takeo, Kondo, Kenji, Iwata, Nakao

    Published in Psychiatry and clinical neurosciences (01-02-2018)
    “…Recent advances in molecular genetics have enabled assessments of the associations among genetic variants (e.g., single‐nucleotide polymorphisms) and…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Efficacy and safety of antipsychotic treatments for schizophrenia: A systematic review and network meta-analysis of randomized trials in Japan by Kishi, Taro, Ikuta, Toshikazu, Sakuma, Kenji, Okuya, Makoto, Iwata, Nakao

    Published in Journal of psychiatric research (01-06-2021)
    “…We examined the efficacy and safety of using antipsychotic medication for schizophrenia using only randomized trials of antipsychotic for schizophrenia…”
    Get full text
    Journal Article